{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:57:16Z","timestamp":1781704636772,"version":"3.54.5"},"reference-count":27,"publisher":"Norwegian Medical Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.17.1055","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T08:39:59Z","timestamp":1547541599000},"source":"Crossref","is-referenced-by-count":4,"title":["Medical management of fistulising Crohn's disease"],"prefix":"10.4045","volume":"139","author":[{"given":"Tore","family":"Grimstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars N.","family":"Karlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Nielsen\u00a0OH, Rogler\u00a0G, Hahnloser\u00a0D et al. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009; 6: 92\u2013106. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19153563&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fncpgasthep1340","DOI":"10.1038\/ncpgasthep1340"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Gecse\u00a0K, Khanna\u00a0R, Stoker\u00a0J et al. Fistulizing Crohn's disease: Diagnosis and management. United European Gastroenterol J 2013; 1: 206\u201313. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24917961&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F2050640613487194","DOI":"10.1177\/2050640613487194"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Schwartz\u00a0DA, Loftus\u00a0EV, Tremaine\u00a0WJ et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875\u201380. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11910338&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1053%2Fgast.2002.32362","DOI":"10.1053\/gast.2002.32362"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Present\u00a0DH, Rutgeerts\u00a0P, Targan\u00a0S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398\u2013405. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10228190&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJM199905063401804","DOI":"10.1056\/NEJM199905063401804"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Sands\u00a0BE, Anderson\u00a0FH, Bernstein\u00a0CN et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 876\u201385. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14985485&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa030815","DOI":"10.1056\/NEJMoa030815"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Colombel\u00a0JF, Schwartz\u00a0DA, Sandborn\u00a0WJ et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009; 58: 940\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19201775&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fgut.2008.159251","DOI":"10.1136\/gut.2008.159251"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Schreiber\u00a0S, Lawrance\u00a0IC, Thomsen\u00a0O\u00d8 et al. Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 185\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21083671&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1365-2036.2010.04509.x","DOI":"10.1111\/j.1365-2036.2010.04509.x"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Sandborn\u00a0WJ, Feagan\u00a0BG, Rutgeerts\u00a0P et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013; 369: 711\u201321. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23964933&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa1215739","DOI":"10.1056\/NEJMoa1215739"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Khorrami\u00a0S, Ginard\u00a0D, Mar\u00edn-Jim\u00e9nez\u00a0I et al. Ustekinumab for the treatment of refractory Crohn's Disease: The Spanish experience in a large multicentre open-label cohort. Inflamm Bowel Dis 2016; 22: 1662\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27306072&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2FMIB.0000000000000842","DOI":"10.1097\/MIB.0000000000000842"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Adegbola\u00a0SO, Sahnan\u00a0K, Tozer\u00a0PJ et al. Review of local injection of anti-TNF for perianal fistulising Crohn's disease. Int J Colorectal Dis 2017; 32: 1539\u201344. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28900730&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00384-017-2899-0","DOI":"10.1007\/s00384-017-2899-0"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Yarur\u00a0AJ, Kanagala\u00a0V, Stein\u00a0DJ et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Aliment Pharmacol Ther 2017; 45: 933\u201340. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28211593&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fapt.13970","DOI":"10.1111\/apt.13970"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Present\u00a0DH, Korelitz\u00a0BI, Wisch\u00a0N et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6102739&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJM198005013021801","DOI":"10.1056\/NEJM198005013021801"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Pearson\u00a0DC, May\u00a0GR, Fick\u00a0GH et al. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132\u201342. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7778826&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.7326%2F0003-4819-123-2-199507150-00009","DOI":"10.7326\/0003-4819-123-2-199507150-00009"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Mahadevan\u00a0U, Marion\u00a0JF, Present\u00a0DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther 2003; 18: 1003\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14616166&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1046%2Fj.1365-2036.2003.01790.x","DOI":"10.1046\/j.1365-2036.2003.01790.x"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Soon\u00a0SY, Ansari\u00a0A, Yaneza\u00a0M et al. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 921\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15316419&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2F00042737-200409000-00018","DOI":"10.1097\/00042737-200409000-00018"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Present\u00a0DH, Lichtiger\u00a0S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39: 374\u201380. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8313821&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2FBF02090211","DOI":"10.1007\/BF02090211"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Klag\u00a0T, Goetz\u00a0M, Stange\u00a0EF et al. Medical therapy of perianal Crohn's disease. Viszeralmedizin 2015; 31: 265\u201372. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26557835&dopt=Abstract","DOI":"10.1159\/000434664"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Sandborn\u00a0WJ, Present\u00a0DH, Isaacs\u00a0KL et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125: 380\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12891539&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0016-5085(03)00877-1","DOI":"10.1016\/S0016-5085(03)00877-1"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Dejaco\u00a0C, Harrer\u00a0M, Waldhoer\u00a0T et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1113\u201320. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14653831&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1046%2Fj.1365-2036.2003.01793.x","DOI":"10.1046\/j.1365-2036.2003.01793.x"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"West\u00a0RL, van der Woude\u00a0CJ, Hansen\u00a0BE et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20: 1329\u201336. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15606395&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1365-2036.2004.02247.x","DOI":"10.1111\/j.1365-2036.2004.02247.x"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Dewint\u00a0P, Hansen\u00a0BE, Verhey\u00a0E et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 2014; 63: 292\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23525574&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fgutjnl-2013-304488","DOI":"10.1136\/gutjnl-2013-304488"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Tozer\u00a0P, Ng\u00a0SC, Siddiqui\u00a0MR et al. Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn's perianal fistulas. Inflamm Bowel Dis 2012; 18: 1825\u201334. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22223472&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fibd.21940","DOI":"10.1002\/ibd.21940"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Bernstein\u00a0LH, Frank\u00a0MS, Brandt\u00a0LJ et al. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 357\u201365. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7399243&dopt=Abstract","DOI":"10.1016\/0016-5085(80)90155-9"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Solomon\u00a0MJ, McLeod\u00a0RS, O'Connor\u00a0BI et al. Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease. Can J Gastroenterol 1993; 7: 571\u20133. Crossref: http:\/\/dx.doi.org\/10.1155%2F1993%2F610272","DOI":"10.1155\/1993\/610272"},{"key":"ref=25","unstructured":"Jakobovits\u00a0J, Schuster\u00a0MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984; 79: 533\u201340. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6741906&dopt=Abstract"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Thia\u00a0KT, Mahadevan\u00a0U, Feagan\u00a0BG et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15: 17\u201324. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18668682&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fibd.20608","DOI":"10.1002\/ibd.20608"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Wu\u00a0XW, Ji\u00a0HZ, Wang\u00a0FY. Meta-analysis of ciprofloxacin in treatment of Crohn's disease. Biomed Rep 2015; 3: 70\u20134. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25469250&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3892%2Fbr.2014.368","DOI":"10.3892\/br.2014.368"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Medikamentell behandling ved fistulerende Crohns sykdom"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:22:34Z","timestamp":1781702554000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2018\/12\/klinisk-oversikt\/medikamentell-behandling-ved-fistulerende-crohns-sykdom"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,15]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.17.1055","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]}}}